![](/img/cover-not-exists.png)
Phase 1 Study of combinatorial sorafenib, GâCSF , and plerixafor treatment in relapsed/refractory, FLT3âITD âmutated acute myelogenous leukemia patients
Borthakur, Gautam, Zeng, Zhihong, Cortes, Jorge E., Chen, HsiangâChun, Huang, Xuelin, Konopleva, Marina, Ravandi, Farhad, Kadia, Tapan, Patel, Keyur P., Daver, Naval, Kelly, Mary A., McQueen, TeresaJournal:
American Journal of Hematology
DOI:
10.1002/ajh.25943
Date:
July, 2020
File:
PDF, 1.52 MB
2020